Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


INTERVIEW: Ramona Sequeira Rolls Out Takeda's American Dream

Executive Summary

Since Ramona Sequeira was made president of Takeda's US business a year ago, she has set out a new strategy that she hopes will add to the turnaround of the Japanese major after a difficult patch in its history.

You may also be interested in...

Takeda Turnaround In Full Flow As New Products Deliver On Promise

Takeda Pharmaceutical Co. Ltd. has closed out its "turnaround year" on target, meeting guidance for fiscal 2015. The company has been undergoing a reorganization to pull it through intense generic competition and CEO Christophe Weber took the year-end opportunity to outline how the strategy was playing out for Japanese pharma.

US site closures as Takeda restructures vaccines business

A fundamental restructuring of Takeda Pharmaceutical's vaccines operations will see the closure of three sites in the US as it consolidates operations in this market in the Boston area as part of a revised global network for the unit.

Takeda Looks Up As It ‘Hits Bottom’

Following the massive financial hit of the recent Actos settlement, Takeda appears set to return to profitable growth this fiscal year after a 12-month period during which its new CEO says the Japanese firm "hit bottom."

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts